These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22553321)

  • 1. Partial escape of HIV-1 from cytotoxic T lymphocytes during chronic infection.
    Lewis MJ; Dagarag M; Khan B; Ali A; Yang OO
    J Virol; 2012 Jul; 86(13):7459-63. PubMed ID: 22553321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.
    Lewis MJ; Lee P; Ng HL; Yang OO
    J Virol; 2012 Jul; 86(13):7126-35. PubMed ID: 22553319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Epitope Variability Is Associated with T Cell Receptor Repertoire Instability and Breadth.
    Balamurugan A; Claiborne D; Ng HL; Yang OO
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD
    J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
    Ganusov VV; Goonetilleke N; Liu MK; Ferrari G; Shaw GM; McMichael AJ; Borrow P; Korber BT; Perelson AS
    J Virol; 2011 Oct; 85(20):10518-28. PubMed ID: 21835793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.
    Borzooee F; Joris KD; Grant MD; Larijani M
    Front Immunol; 2018; 9():3032. PubMed ID: 30687306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection.
    Turnbull EL; Baalwa J; Conrod KE; Wang S; Wei X; Wong M; Turner J; Pellegrino P; Williams I; Shaw GM; Borrow P
    Retrovirology; 2011 Jun; 8():41. PubMed ID: 21635736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape.
    Bailey JR; Zhang H; Wegweiser BW; Yang HC; Herrera L; Ahonkhai A; Williams TM; Siliciano RF; Blankson JN
    J Infect Dis; 2007 Jul; 196(1):50-5. PubMed ID: 17538883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variation.
    Honeyborne I; Codoñer FM; Leslie A; Tudor-Williams G; Luzzi G; Ndung'u T; Walker BD; Goulder PJ; Prado JG
    J Virol; 2010 Nov; 84(21):11279-88. PubMed ID: 20739527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.
    Yang OO; Sarkis PT; Ali A; Harlow JD; Brander C; Kalams SA; Walker BD
    J Exp Med; 2003 May; 197(10):1365-75. PubMed ID: 12743169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
    Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HIV-specific CD8
    Leitman EM; Thobakgale CF; Adland E; Ansari MA; Raghwani J; Prendergast AJ; Tudor-Williams G; Kiepiela P; Hemelaar J; Brener J; Tsai MH; Mori M; Riddell L; Luzzi G; Jooste P; Ndung'u T; Walker BD; Pybus OG; Kellam P; Naranbhai V; Matthews PC; Gall A; Goulder PJR
    J Exp Med; 2017 Nov; 214(11):3239-3261. PubMed ID: 28983013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia.
    Yang OO; Daar ES; Ng HL; Shih R; Jamieson BD
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):391-8. PubMed ID: 21087140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.